| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/14/1999 | WO1999023252A1 Cancer gene |
| 05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
| 05/14/1999 | WO1999023229A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | WO1999023219A1 Human slit polypeptide and polynucleotides encoding same |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023216A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 05/14/1999 | WO1999023215A2 Materials and methods for preventing cellular injury in humans and animals |
| 05/14/1999 | WO1999023108A1 Inducible phosphofructokinase and the warburg effect |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999022773A2 Sequences for targeting metastatic cells |
| 05/14/1999 | WO1999022771A1 Cell-specific molecule and method for importing dna into a nucleus |
| 05/14/1999 | WO1999022760A1 Method and compositions for inhibiting angiogenesis and treating cancer |
| 05/14/1999 | WO1999022742A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | WO1999008712A3 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES |
| 05/14/1999 | WO1999005269A8 Transcriptional silencer protein nrf |
| 05/14/1999 | WO1999004265A8 Cancer associated nucleic acids and polypeptides |
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | WO1998052603A3 An influenza enveloped dna vaccine |
| 05/14/1999 | WO1998033904A3 An antisense oligonucleotide preparation method |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/14/1999 | CA2308852A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | CA2308575A1 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 05/14/1999 | CA2308565A1 Sequences for targeting metastatic cells |
| 05/14/1999 | CA2308438A1 Method and compositions for inhibiting angiogenesis and treating cancer |
| 05/14/1999 | CA2308091A1 Inducible phosphofructokinase and the warburg effect |
| 05/14/1999 | CA2308017A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/12/1999 | EP0915166A1 DNA virus vectors and methods for their production |
| 05/12/1999 | EP0915165A1 Method for the helper virus-free packaging of a DNA-vector |
| 05/12/1999 | EP0915164A2 RncS, a ribonuclease from Staphylococcus aureus |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae |
| 05/12/1999 | EP0915156A1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/12/1999 | EP0914461A2 Method for enhancing gene transfer |
| 05/12/1999 | EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 05/12/1999 | EP0914456A1 Gene expression in monocytes and macrophages |
| 05/12/1999 | EP0914448A1 Lipid kinase |
| 05/12/1999 | EP0914444A1 Vectors comprising sar elements |
| 05/12/1999 | EP0914443A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
| 05/12/1999 | EP0914442A1 Avian polynucleotide vaccine formula |
| 05/12/1999 | EP0914440A1 Nucleic acid vaccination for parvoviral infections |
| 05/12/1999 | EP0914434A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 05/12/1999 | EP0914432A2 Secreted proteins and polynucleotides encoding them |
| 05/12/1999 | EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 05/12/1999 | EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 05/12/1999 | EP0914426A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
| 05/12/1999 | EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression |
| 05/12/1999 | EP0914422A1 Mammalian genes involved in viral infection and tumor suppression |
| 05/12/1999 | EP0914421A2 Hepatitis c virus ribozymes |
| 05/12/1999 | EP0914418A1 Method for producing therapeutic dna |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914325A1 Modulators of the function of fas receptors and other proteins |
| 05/12/1999 | EP0914163A1 Novel processes implementing selective immune down regulation (sidr) |
| 05/12/1999 | EP0914145A1 Methods of controlling axonal growth |
| 05/12/1999 | EP0914142A1 Peptides with increased binding affinity for hla molecules |
| 05/12/1999 | DE19840875A1 Tumor-suppressing protein conductin |
| 05/12/1999 | DE19747719A1 Genetic therapy of bone disorders by expressing proteins |
| 05/12/1999 | CN1216584A Immunity to trypanosomatids species |
| 05/12/1999 | CA2220805A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 05/11/1999 | US5902880 RNA polymerase III-based expression of therapeutic RNAs |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902576 Antitumor pharmaceutical composition comprising IL-6 transfected cells |
| 05/06/1999 | WO1999022000A1 Inhibitor protein of the wnt signal pathway |
| 05/06/1999 | WO1999021996A1 Methods and compositions for the diagnosis and treatment of cataracts |
| 05/06/1999 | WO1999021992A2 Nucleic acid molecules encoding a glutamate receptor |
| 05/06/1999 | WO1999021988A1 THE HUMAN VESICLE TRAFFICKING PROTEIN SEC22b GENE OF CBFBBA01 |
| 05/06/1999 | WO1999021986A1 Cbfbga09: a human sl15 homolog |
| 05/06/1999 | WO1999021979A1 Human papillomavirus vectors |
| 05/06/1999 | WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 05/06/1999 | WO1999021875A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 05/06/1999 | WO1999021591A1 Compositions and methods for delivery of genetic material |
| 05/06/1999 | WO1999021590A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | WO1999021589A2 Use of vectors such as adenoviruses and/or adeno associated viruses and/or retroviruses and/or herpes simplex viruses and/or liposomes and/or plasmids as a vehicle for genetic information enabling mammal cells to produce agents for the treatment of bone pathologies |
| 05/06/1999 | WO1999015683A8 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 05/06/1999 | WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 05/06/1999 | WO1999012963A3 Cysteine rich receptors: trail |
| 05/06/1999 | WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 05/06/1999 | WO1999009192A9 Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells |
| 05/06/1999 | WO1999009164A9 Coding sequence haplotypes of the human brca2 gene |
| 05/06/1999 | WO1999009156A3 Protease-related protein |
| 05/06/1999 | WO1999009045A9 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 05/06/1999 | WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |
| 05/06/1999 | EP0913479A2 Adenine glycosylase |
| 05/06/1999 | EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993 |
| 05/06/1999 | EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase |
| 05/06/1999 | EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof |
| 05/06/1999 | EP0913474A2 Dbpa, a helicase from Staphylococcus aureus |
| 05/06/1999 | EP0913472A2 Human LIG-1 Homolog (HLIG-1) |
| 05/06/1999 | EP0912747A1 Aspartic protease |
| 05/06/1999 | EP0912744A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences |
| 05/06/1999 | EP0912743A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 05/06/1999 | EP0912740A1 Rantes homolog from prostate |
| 05/06/1999 | EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/06/1999 | EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 05/06/1999 | EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces |
| 05/06/1999 | EP0912723A1 Highly productive packaging lines |